PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells

被引:8
|
作者
Dansu, David K. [1 ,2 ]
Liang, Jialiang [3 ,4 ]
Selcen, Ipek [1 ,2 ]
Zheng, Haiyan [5 ,6 ]
Moore, Dirk F. [7 ]
Casaccia, Patrizia [1 ,2 ]
机构
[1] CUNY, Adv Sci Res Ctr, Neurosci Initiat, New York, NY 10021 USA
[2] CUNY, Grad Ctr, Grad Program Biochem, New York, NY 10021 USA
[3] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY USA
[5] Ctr Adv Biotechnol & Med, Piscataway, NJ USA
[6] Rutgers Biomed & Hlth Sci, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ USA
[7] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA
关键词
brain; arginine methylation; RNA processing; epigenetics; iTRAQ; HISTONE DEACETYLASE ACTIVITY; METHYLTRANSFERASE; 7; PRMT7; 3 MAJOR FORMS; ARGININE METHYLATION; CEREBROSPINAL-FLUID; SM PROTEINS; RNA; IDENTIFICATION; EXPRESSION; COMPLEX;
D O I
10.3389/fncel.2022.820226
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The protein arginine methyl transferase PRMT5 is an enzyme expressed in oligodendrocyte lineage cells and responsible for the symmetric methylation of arginine residues on histone tails. Previous work from our laboratory identified PRMT5 as critical for myelination, due to its transcriptional regulation of genes involved in survival and early stages of differentiation. However, besides its nuclear localization, PRMT5 is found at high levels in the cytoplasm of several cell types, including oligodendrocyte progenitor cells (OPCs) and yet, its interacting partners in this lineage, remain elusive. By using mass spectrometry on protein eluates from extracts generated from primary oligodendrocyte lineage cells and immunoprecipitated with PRMT5 antibodies, we identified 1196 proteins as PRMT5 interacting partners. These proteins were related to molecular functions such as RNA binding, ribosomal structure, cadherin and actin binding, nucleotide and protein binding, and GTP and GTPase activity. We then investigated PRMT5 substrates using iTRAQ-based proteomics on cytosolic and nuclear protein extracts from CRISPR-PRMT5 knockdown immortalized oligodendrocyte progenitors compared to CRISPR-EGFP controls. This analysis identified a similar number of peptides in the two subcellular fractions and a total number of 57 proteins with statistically decreased symmetric methylation of arginine residues in the CRISPR-PRMT5 knockdown compared to control. Several PRMT5 substrates were in common with cancer cell lines and related to RNA processing, splicing and transcription. In addition, we detected ten oligodendrocyte lineage specific substrates, corresponding to proteins with high expression levels in neural tissue. They included: PRC2C, a proline-rich protein involved in methyl-RNA binding, HNRPD an RNA binding protein involved in regulation of RNA stability, nuclear proteins involved in transcription and other proteins related to migration and actin cytoskeleton. Together, these results highlight a cell-specific role of PRMT5 in OPC in regulating several other cellular processes, besides RNA splicing and metabolism.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] PRMT5 AS A DRUGGABLE TARGET FOR GLIOBLASTOMA THERAPY
    Banasavadi-Siddegowda, Yeshavanth Kumar
    Welker, Alessandra M.
    Imitola, Jaime
    Li, Chenglong
    Zhang, Jianying
    Beattie, Christine E.
    Baiocchi, Robert
    Kaur, Balveen
    NEURO-ONCOLOGY, 2017, 19 : 78 - 78
  • [32] Medicinal chemistry insights into PRMT5 inhibitors
    Jiao, Zhihao
    Huang, Yongmi
    Gong, Kexin
    Liu, Yiru
    Sun, Jinxiao
    Yu, Shangzhe
    Zhao, Guisen
    BIOORGANIC CHEMISTRY, 2024, 153
  • [33] PRMT5 is a Poor Prognostic Marker for NSCLC and Inhibition of PRMT5 Results in Increased Lung Cancer Sensitivity to Cisplatin and Radiotherapy
    Welliver, Meng
    Jin, Feng
    Otterson, Gregory
    Carbone, David
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S844 - S844
  • [34] Targeting prmt5 inhibits DNA repair and enhances the radiosensitivity of GBM cells
    Degorre, Charlotte M.
    Lohard, Steven
    Tofilon, Philip J.
    CANCER RESEARCH, 2023, 83 (07)
  • [35] PRMT5 and the role of symmetrical dimethylarginine in chromatoid bodies of planarian stem cells
    Rouhana, Labib
    Vieira, Ana P.
    Roberts-Galbraith, Rachel H.
    Newmark, Phillip A.
    DEVELOPMENT, 2012, 139 (06): : 1083 - 1094
  • [36] Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo
    Degorre, Charlotte
    Lohard, Steven
    Bobrek, Christina N.
    Rawal, Komal N.
    Kuhn, Skyler
    Tofilon, Philip J.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] Linking PRMT5 to breast cancer stem cells: New therapeutic opportunities?
    Chiang, Kelly
    Davies, Clare C.
    MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (03):
  • [38] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
    Lin, Hong
    Luengo, Juan, I
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269
  • [39] Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells
    Mongiardi, Maria Patrizia
    Savino, Mauro
    Bartoli, Laura
    Beji, Sara
    Nanni, Simona
    Scagnoli, Fiorella
    Falchetti, Maria Laura
    Favia, Annarita
    Farsetti, Antonella
    Levi, Andrea
    Nasi, Sergio
    Illi, Barbara
    SCIENTIFIC REPORTS, 2015, 5
  • [40] Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
    Palte, Rachel L.
    Schneider, Sebastian E.
    Altman, Michael D.
    Hayes, Robert P.
    Kawamura, Shuhei
    Lacey, Brian M.
    Mansueto, My Sam
    Reutershan, Michael
    Siliphaivanh, Phieng
    Sondey, Christopher
    Xu, Haiyan
    Xu, Zangwei
    Ye, Yingchun
    Machacek, Michelle R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1688 - 1693